Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Thyroid functional disease, and in particular hypothyroidism, is highly prevalent among chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients. In the general population, hypothyroidism is associated with impaired cardiac contractility, endothelial dysfunction, atherosclerosis and possibly higher cardiovascular mortality. It has been hypothesized that hypothyroidism is an under-recognized, modifiable risk factor for the enormous burden of cardiovascular disease and death in CKD and ESRD, but this has been difficult to test due to the challenge of accurate thyroid functional assessment in uremia. Low thyroid hormone levels (i.e. triiodothyronine) have been associated with adverse cardiovascular sequelae in CKD and ESRD patients, but these metrics are confounded by malnutrition, inflammation and comorbid states, and hence may signify nonthyroidal illness (i.e. thyroid functional test derangements associated with underlying ill health in the absence of thyroid pathology). Thyrotropin is considered a sensitive and specific thyroid function measure that may more accurately classify hypothyroidism, but few studies have examined the clinical significance of thyrotropin-defined hypothyroidism in CKD and ESRD. Of even greater uncertainty are the risks and benefits of thyroid hormone replacement, which bear a narrow therapeutic-to-toxic window and are frequently prescribed to CKD and ESRD patients. In this review, we discuss mechanisms by which hypothyroidism adversely affects cardiovascular health; examine the prognostic implications of hypothyroidism, thyroid hormone alterations and exogenous thyroid hormone replacement in CKD and ESRD; and identify areas of uncertainty related to the interplay between hypothyroidism, cardiovascular disease and kidney disease requiring further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279 · cited 1×
“Hypothyroidism is a relatively common endocrine disorder in the general population, with a prevalence of 5–10% in most US cohort studies [36, 37].”
BackgroundThe Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300 · cited 7×
“In terms of the former pathway, hypothyroidrelated reductions in cardiac output, rises in peripheral vascular resistance, and intra-renal vasoconstriction may decrease renal blood flow and predispose to prerenal kidney injury [18, 21, 102, 103].”
BackgroundInfluentialBianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418 · cited 1×
“Studies in the general population have shown that hypothyroidism is associated with increased cardiovascular morbidity and possibly mortality, owing to its adverse effects on cardiac contractility, systemic vascular resistance, endothelial function and atherosclerosis [19–21].”
BackgroundKlein, I., & Danzi, S. (2007) · Circulation · doi:10.1161/circulationaha.106.678326 · Cited by 1,324
Mechanisms of thyroid hormone action
Brent, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60047 · Cited by 1,244 · cited 2×
“Thyroid hormone directly affects gene expression by binding to thyroid hormone nuclear receptors which then affect gene transcription by binding to thyroid hormone response elements of target genes [64].”
BackgroundSelf-citationCellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891 · cited 2×
“It is now thought that in humans, D2 is the primary contributor to the peripheral production of T3 [44].”
BackgroundThyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W. (2006) · JAMA · doi:10.1001/jama.295.9.1033 · Cited by 862
Duntas, L. H. (2002) · Thyroid · doi:10.1089/10507250252949405 · Cited by 725
Subclinical thyroid dysfunction as a risk factor for cardiovascular disease
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2467 · Cited by 536 · cited 1×
“Some [81– 83], but not all [84], epidemiologic studies have shown that subclinical hypothyroidism may also be associated with ischemic heart disease.”
BackgroundGencer, B., Collet, T.-H., Virgini, V., Bauer, D. C., Gussekloo, J., Cappola, A. R., Nanchen, D., den Elzen, W. P. J., Balmer, P., Luben, R. N., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.096024 · Cited by 517 · cited 1×
“Some observational studies and meta-analyses have shown that even subclinical hypothyroidism may be associated with greater CHF risk [74, 75].”
BackgroundSubclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death
Rodondi, N., Newman, A. B., Vittinghoff, E., de Rekeneire, N., Satterfield, S., Harris, T. B., & Bauer, D. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2460 · Cited by 503 · cited 1×
“Some observational studies and meta-analyses have shown that even subclinical hypothyroidism may be associated with greater CHF risk [74, 75].”
BackgroundMeta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
Ochs, N., Auer, R., Bauer, D. C., Nanchen, D., Gussekloo, J., Cornuz, J., & Rodondi, N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00225 · Cited by 477 · cited 1×
“Several meta-analyses have examined the association between subclinical hypothyroidism and mortality, and despite considerable dissimilarities in patient populations, the overall results show a trend towards increased mortality in individuals with subclinical hypothyroidism, particularly among those with higher TSH le…”
ResultMonzani, F., Caraccio, N., Kozàkowà, M., Dardano, A., Vittone, F., Virdis, A., Taddei, S., Palombo, C., & Ferrannini, E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031669 · Cited by 399 · cited 1×
“Studies in the general population indicate that restoration of euthyroid status favorably affects cardiovascular risk profiles, and limited data suggest that treatment of subclinical hypothyroidism may reduce cardiovascular events particularly in younger populations [172–176].”
BackgroundType 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans
Luiza Maia, A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25083 · Cited by 360 · cited 1×
“Circulating thyroid hormones enter peripheral cells by thyroid hormone transporters or diffusion across the plasma membrane, and intracellular metabolism of T4-to-T3 accounts for the majority (∼80%) of extrathyroidal T3 produced from T4 [64, 65].”
BackgroundLeft Ventricular Diastolic Dysfunction in Patients with Subclinical Hypothyroidism
Biondi, B., Fazio, S., Palmieri, E. A., Carella, C., Panza, N., Cittadini, A., Bonè, F., Lombardi, G., & Saccà, L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5733 · Cited by 334 · cited 1×
“Studies in the general population indicate that restoration of euthyroid status favorably affects cardiovascular risk profiles, and limited data suggest that treatment of subclinical hypothyroidism may reduce cardiovascular events particularly in younger populations [172–176].”
BackgroundMonzani, F., Di Bello, V., Caraccio, N., Bertini, A., Giorgi, D., Giusti, C., & Ferrannini, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7291 · Cited by 308
CHOPRA, I. J., WILLIAMS, D. E., ORGIAZZI, J., & SOLOMON, D. H. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-5-911 · Cited by 302
Association between increased mortality and mild thyroid dysfunction in cardiac patients
Iervasi, G. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1526 · Cited by 285 · cited 1×
“recent cardiac events or CHD risk factors) have observed that subclinical hypothyroidism is associated with greater all-cause and cardiovascular mortality [93–95], this has not been consistently observed in average risk groups [84].”
BackgroundKvetny, J., Heldgaard, P. E., Bladbjerg, E. M., & Gram, J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02088.x · Cited by 280
Razvi, S., Weaver, J. U., Butler, T. J., & Pearce, S. H. S. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.1159 · Cited by 266
Consistent Reversible Elevations of Serum Creatinine Levels in Severe Hypothyroidism
Kreisman, S. H., & Hennessey, J. V. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.79 · Cited by 219 · cited 2×
“Case series have observed that severely hypothyroid patients have reduced renal plasma flow and GFR measured by creatininebased estimating equations and isotopic scans, which were reversed with thyroid hormone replacement [108–111].”
BackgroundCoordination of hypothalamic and pituitary T3 production regulates TSH expression
Fonseca, T. L., Correa-Medina, M., Campos, M. P. O., Wittmann, G., Werneck-de-Castro, J. P., Arrojo e Drigo, R., Mora-Garzon, M., Ueta, C. B., Caicedo, A., Fekete, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci61231 · Cited by 155
Shin, D. H., Lee, M. J., Kim, S. J., Oh, H. J., Kim, H. R., Han, J. H., Koo, H. M., Doh, F. M., Park, J. T., Han, S. H., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1663 · Cited by 138 · cited 1×
“Two cohort studies have shown that thyroid hormone replacement in CKD patients with subclinical hypothyroidism was associated with greater kidney function preservation compared with nontreatment [112, 113].”
BackgroundHaemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease
Müller, B., Tsakiris, D. A., Roth, C. B., Guglielmetti, M., Staub, J. ‐., & Marbet, G. A. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00777.x · Cited by 136 · cited 1×
“Limited and mixed data suggest that hypothyroidism may be associated with both impaired hemostasis (due to decreased von Willebrand and coagulation factor levels and activity) and hypercoagulability (due to increased coagulation factor activity) [151–155].”
Backgroundvan Deventer, H. E., Mendu, D. R., Remaley, A. T., & Soldin, S. J. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.154088 · Cited by 108
Torpy, D. J., Tsigos, C., Lotsikas, A. J., Defensor, R., Chrousos, G. P., & Papanicolaou, D. A. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90338-9 · Cited by 95 · cited 1×
“hypothalamic–pituitary–thyroid axis) thyroid hormone metabolism (nonthyroidal illness) [159, 160].”
Subclinical hypothyroidism and survival: the effects of heart failure and race
Rhee, C. M., Curhan, G. C., Alexander, E. K., Bhan, I., & Brunelli, S. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1039 · Cited by 83 · cited 1×
“A recent study of NHANES III participants demonstrated that subclinical hypothyroidism is associated with greater death risk in those with CHF but not in those without [96].”
BackgroundSelf-citationBoelen, A., Kwakkel, J., Wiersinga, W. M., & Fliers, E. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.07056 · Cited by 64
Cited by
Romagnani, P., Remuzzi, G., Glassock, R., Levin, A., Jager, K. J., Tonelli, M., Massy, Z., Wanner, C., & Anders, H.-J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.88 · Cited by 996
The interaction between thyroid and kidney disease: an overview of the evidence.
Rhee, C. M. (2016) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000275 · Cited by 135
Self-citationDIAGNOSIS OF ENDOCRINE DISEASE: How reliable are free thyroid and total T3 hormone assays?
Welsh, K. J., & Soldin, S. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0193 · Cited by 124
Rhee, C. M., Kim, S., Gillen, D. L., Oztan, T., Wang, J., Mehrotra, R., Kuttykrishnan, S., Nguyen, D. V., Brunelli, S. M., Kovesdy, C. P., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4311 · Cited by 67
Self-citationThyroid functional disease and mortality in a national peritoneal dialysis cohort.
Rhee, C. M., Ravel, V. A., Streja, E., Mehrotra, R., Kim, S., Wang, J., Nguyen, D. V., Kovesdy, C. P., Brent, G. A., & Kalantar-Zadeh, K. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1691 · Cited by 36
Self-citation
Metadata
- Authors
- Rhee, C. M., Brent, G. A., Kovesdy, C. P., Soldin, O. P., Nguyen, D., Budoff, M. J., Brunelli, S. M., & Kalantar-Zadeh, K.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-02-25
- Volume
- 30
- Issue
- 5
- Pages
- 724-737
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2146920380
- Cited by
- 99
- References
- 31
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.